U.S Pharmaceutical Packaging Product Market - 2024-2031

The U.S pharmaceutical packaging product market reached US$ 75.1 billion in 2023 and is expected to reach US$ 130.3 billion by 2033, growing at a CAGR of 9.5% during the forecast period 2024-2031.

Pharmaceutical packaging involves the process of dividing, sealing, packaging, and labeling semi-finished or finished pharmaceutical products with appropriate materials or containers. It provides quality assurance, trademark identification, and drug descriptions. The packaging can be static or dynamic, and its role in circulation can be divided into inner and outer packaging. Its functions include protection, convenient application, and product promotion. The technical methods of containers and auxiliary materials are processes and operations. The role of drug packaging in circulation can be divided into inner and outer packaging.

Market Dynamics: Drivers & Restraints

Growing Demand for Advanced Drug Delivery Systems and Biologics

The US pharmaceutical packaging market is being significantly shaped by the increasing demand for advanced drug delivery systems and biologics. These systems, such as prefilled syringes, auto-injectors, and transdermal patches, are favored due to their ability to improve patient compliance, precise dosing, and treatment efficacy. The growing prevalence of chronic diseases like diabetes, cardiovascular disorders, and autoimmune conditions necessitates consistent and precise medication delivery. The growing market for biologics, including monoclonal antibodies, vaccines, and gene therapies, demands specialized packaging solutions to ensure product stability, sterility, and protection from external factors.

For instance, in September 2024, PCI Pharma Services, a leading global contract development and manufacturing organization, is invested over $365 Billion in infrastructure for the final assembly and packaging of drug-device combination products using advanced drug delivery systems. The investment is part of PCI's global investment plan, funded by recent new business, and aims to accommodate future growth in injectable formats.

High Cost of Developing Advanced Packaging Solutions

The U.S. pharmaceutical packaging market faces significant challenges due to the high cost of developing advanced packaging solutions. The complexity of packaging requirements for biologics, controlled drug delivery systems, and personalized medicines necessitates specialized materials and technologies, increasing production costs and burdening manufacturers, especially small and medium-sized enterprises. Stringent regulatory standards and the shift towards sustainable packaging also pose challenges, as the development and sourcing of eco-friendly materials require additional investment and innovation. These cost-related barriers may limit the widespread adoption of advanced packaging solutions, particularly in price-sensitive segments, restraining market growth.

Segment Analysis

The U.S pharmaceutical packaging product market is segmented based on packaging type, drug type, material type and end user.

Packaging Type:

Primary Packaging segment is expected to dominate the pharmaceutical packaging product market share

The primary packaging segment holds a major portion of the pharmaceutical packaging product market share and is expected to continue to hold a significant portion of the pharmaceutical packaging product market share during the forecast period.

Primary packaging is a crucial component in the U.S. pharmaceutical market, ensuring the safety, efficacy, and integrity of pharmaceutical products. It protects medications from external factors like moisture, light, oxygen, and contamination. Products like blister packs, bottles, vials, ampoules, and prefilled syringes are essential for safeguarding drug formulations, particularly sensitive biologics and controlled-release drugs. User-friendly designs and advancements in materials and technologies enhance the functionality and sustainability of primary packaging, aligning with regulatory requirements and environmental concerns. As the pharmaceutical market grows, primary packaging remains essential for maintaining product quality and meeting evolving needs.

For instance, in January 2024, TekniPlex Healthcare, a Pennsylvania-based materials science and packaging company, has partnered with Alpek Polyester to launch a pharmaceutical-grade PET blister film with 30% postconsumer recycled monomers. The film-plus-lidding blister system is fully recyclable in the polyester recycling stream when combined with Teknilid Push polyester lidding. This marks the first time pharmaceutical companies can incorporate a fully recyclable blister pack while meeting stringent quality standards for product protection and consumer safety.

Material Type:

Material type segment is the fastest-growing segment in the pharmaceutical packaging product market share

The material type segment is the fastest-growing segment in the pharmaceutical packaging product market share and is expected to hold the market share over the forecast period.

Plastic is a crucial material in the U.S. pharmaceutical packaging market due to its versatility, safety, convenience, and functionality. Its lightweight, cost-effective, and customizable properties make it suitable for various packaging applications, including bottles, containers, blister packs, vials, and syringes. Plastics like PE, PP, and PVC are valued for their protective qualities, such as resistance to moisture, oxygen, and light, which preserve drug stability and extend shelf life. Prefilled syringes and auto-injectors have revolutionized drug delivery systems, offering ease of use, accurate dosing, and enhanced patient compliance. Advancements in polymer science have led to the incorporation of high-barrier plastics and innovative features like tamper-evident seals and child-resistant closures.

For instance, in October 2024, Parcel Health, a leading sustainable pharmaceutical packaging company, has launched Tully Tube, the world's first paper-based, child-resistant prescription pill bottle. The company aims to displace 1 Billion plastic pill vials by mid-2025 using safer parcels. Since its first shipment on August 30, Parcel Health has prevented over 150,000 plastic pill vials from entering the waste stream, addressing the global plastic waste crisis.

Competitive Landscape

The major U.S players in the pharmaceutical packaging product market include Berry Global Group, Inc, Omnicell, Inc, McKesson Corporation , Cardinal Health Inc, Becton, Dickinson and Company, Sealed Air Corporation, COMAR, LLC, AptarGroup, Inc, American FlexPack, Inc, West Rock Company among others.

Emerging Players

The emerging players in the pharmaceutical packaging product market include Oliver Healthcare Packaging, Tekni-Plex, Inc and among others.

Key Developments

• In November 2024, Safecor Health has acquired the U.S. unit-dose packaging business of Viatris Inc., formerly known as Unit Dose Laboratories (UDL). The acquisition will further Safecor's goal of providing world-class packaging and supply chain solutions to manufacturers and health systems. The acquisition will increase the number of unit-dose commercial products offered and plan to grow the offering with expanded manufacturer, health system, and wholesaler relationships. UDL, founded in 1980, became a national leader in providing unit-dose generic medicines to institutional and long-term care facilities.
• In July 2023, Corning has introduced Corning Viridian Vials, a new pharmaceutical glass-packaging innovation that combines performance and sustainability. The technology can improve filling-line efficiency by up to 50% and reduce vial-manufacturing carbon-dioxide-equivalent emissions by up to 30%. Corning Life Sciences' Ron Verkleeren emphasized the company's commitment to pushing glass technology boundaries to help customers deliver medications safely and efficiently, benefiting patients and the environment.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The U.S pharmaceutical packaging product market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.